A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

Clinical trial NCT05055791 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05055791
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Lymphoma Multiple Myeloma

Start date: 2021-12-29
Primary completion: 2026-06-20
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.